I am as positive that you are a legit new poster just as much as I was positive that poor KGRichards lost his dear sister in law in Saginaw to sepsis a few years ago while waiting an vain for Cytosorb in the US.
The study you are looking for doesn’t exist because management decided that it was better to use their limited funds elsewhere. And since they now have an annual sales rate of around 25 million, instead of still being in a really long expensive sepsis trial, I think they made the right decision. Now they can work on designing a sepsis trial to run when they are cash flow positive and they have a huge amount of data to draw from to help with patient selection and trial details.
Lakersrback, did you email the company like I advised you to do. Im sure they can get you the study you want. If you really don't believe this is a life saving product, you should sell your 10 shares and move on.
News 
Market Data 
Discover 
